YN321152 Metoprolol 51384-51-1

Metoprolol is a cardioselective β1-adrenergic blocking agent with log Kd values of −7.26±0.07, −6.89±0.09, −5.16±0.12 for β1, β2, and β3 adrenoceptors, respectively. It is used for acute myocardial infarction, heart failure, an...

YN321147 Carteolol hydrochloride 51781-21-6

Carteolol HCl is a β-adrenoceptor antagonist, used for the treatment of glaucoma.

YN321026 ICI 89406 53671-71-9

ICI 89406 is a selectiveβ1 adrenergic receptorantagonist amenable to labelling with positron emitters, for PET.

YN320050 Rilmenidine 54187-04-1

Rilmenidine, an innovative antihypertensive agent, is an orally active, selectiveI1 imidazoline receptoragonist. Rilmenidine is analpha 2-adrenoceptoragonist. Rilmenidine inducesautophagy. Rilmenidine acts both centrally by reducing sy...

YN320776 Mapenterol hydrochloride 54238-51-6

Mapenterol hydrochloride is a type ofβ2-adrenoceptoragonist.

YN321154 Metoprolol Tartrate 56392-17-7

Metoprolol Tartrate is a selective β1 receptor blocker medication, used to treat hypertension and heart failure.

YN321693 (R)-(+)-Atenolol 56715-13-0

(R)-(+)-Atenolol binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists.

YN322105 Tulobuterol hydrochloride 56776-01-3

Tulobuterol is a long-acting β2-adrenergic receptor agonist that has bronchodilatory, anti-inflammatory, and antiviral activities.

YN321479 Naftopidil 57149-07-2

Naftopidil is a selective α1-adrenergic receptor antagonist with Ki of 3.7 nM, 20 nM, and 1.2 nM for α1a, α1b, and α1d, respectively, used for the treatment of benign prostatic hyperplasia.

YN321480 Naftopidil dihydrochloride 57149-08-3

Naftopidil DiHCl is a selective 5-HT1A and α1-adrenergic receptor antagonist with IC50 of 0.1 μM and 0.2 μM, respectively.

YN320638 Indoramin D5 57165-41-0

Indoramin D5 is deuterium labeled Indoramin, which is a piperidine antiadrenergic agent.

YN321634 Celiprolol hydrochloride 57470-78-7

Celiprolol is a β1-adrenoceptor antagonist with partial β2 agonist activity.

YN321279 HOKU-81 58020-43-2

HOKU-81 (4-Hydroxytulobuterol) is one of the metabolites of Tulobuterol (HY-B1810). HOKU-81 is a potent and selectiveβ2-adrenoceptorstimulant. HOKU-81 has bronchodilating effect.

YN322008 Pamatolol 59110-35-9

Pamatolol is a cardioselectivebeta-adrenoceptorantagonist without sympathomimetic activity.

YN321551 Brimonidine 59803-98-4

Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2) and is used for the treatment of open-angle glaucoma or ocular hypertension to lower intraocular pressure.

YN320279 Bufuralol hydrochloride 60398-91-6

Bufuralol hydrochloride (Ro 3-4787 hydrochloride) is a potent non-selective, orally activeβ-adrenoreceptorantagonist with partial agonist activity. Bufuralol hydrochloride is a CYP2D6 probe substrate.

YN321468 Terazosin hydrochloride 63074-08-8

Terazosin is a selective alpha-1 antagonist used for treatment of symptoms of an enlarged prostate (BPH). It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.

YN321464 Terazosin 63590-64-7

Terazosin is a quinazoline derivative and a competitive and orally activeα1-adrenoceptorantagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperpl...

YN321474 Betaxolol 63659-18-7

Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.

YN321475 Betaxolol hydrochloride 63659-19-8

Betaxolol is a β1 adrenergic receptor blocker with IC50 of 6 μM.